Skip to content

Calls

Call 2026, 2027 & 2028 is open.
Your next opportunity starts here.
Apply now—the round closes Tuesday, 30 June.

Check the calls – Register on the portal – Upload your Expression of Interest Form – Become a Grasshopper and join our mission !!!

If you don’t see your secondment listed, feel free to contact us at
📩 [email protected]
We’re happy to explore the possibilities together.

Register to apply Read more

Scope of the secondments

Grasshoppers can take part in funded secondments, choosing from the calls below. These secondments foster the exchange of expertise and knowledge at both a technological and tumor-type level, accelerating progress in pediatric cancer treatment.

The secondments are structured around four key objectives (Work Packages, WP), aligned with our research areas:

  • Immune interventions (WP3) and new molecular interventions (WP4) in translational research
  • Repurposing adult cancer medicine for pediatric use (WP5)
  • Developing clinical trials to bring new treatments to patients (WP6)

By joining a GRASSHOPPER secondment, you’ll gain hands-on experience, collaborate with leading experts, and contribute to advancing pediatric oncology across Europe and beyond. Explore the secondment opportunities and apply below!

Secondments

Calls

Call 2026, 2027 & 2028 is open.
Your next opportunity starts here.
Apply now—the round closes Tuesday, 30 June.

Check the calls – Register on the portal – Upload your Expression of Interest Form – Become a Grasshopper and join our mission !!!

If the desired exchange is not listed, but you are interested in an exchange with one of the hosting institutes, please contact the Grasshopper Management Team at [email protected] to discuss opportunities.

 

 

Application Flow
Sending: Princess Máxima Center (NL) to Hosting: Roche (CH

6 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: Princess Máxima Center (NL) to Hosting: DKFZ-KiTZ (DE)

Content: 6 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: Princess Máxima Center (NL) to Hosting: IBRI (US)

12 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: Princess Máxima Center (NL)

6 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: Roche (CH)

Content: 8 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: CCI (AU)

9 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: UCL (UK)

3 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: IBRI (US)

12 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: Princess Máxima Center (NL)

6 months secondment,  WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: DKFZ-KiTZ (DE) to Hosting: Roche (CH)

8 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: Institut Curie (FR) to Hosting: Princess Máxima Center (NL)

Content: 4 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: Institut Curie (FR) to Hosting: Princess Máxima Center (NL)

Content: 5 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: Institut Curie (FR) to Hosting: Princess Máxima Center (NL)

Content: 5 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: Institut Curie (FR) Hosting: Princess Máxima Center (NL)

Content: 5 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: Institut Curie (FR) to Hosting: CCI (AU)

3 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: Region Hovedstaden-Rigs (DK) to Hosting: Roche (CH)

6 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: Region Hovedstaden-Rigs (DK) to Hosting: Princess Máxima Center (NL)

3 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: Region Hovedstaden-Rigs (DK) to Hosting: Roche (CH)

6 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: Region Hovedstaden-Rigs (DK) to Hosting: Princess Máxima Center (NL)

4 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: SJD (ES) to Hosting: Region Hovedstaden-Rigs (DK)

6 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: SJD (ES) to Hosting: IBRI (US)

6 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: NKUA (GR) to Hosting: Princess Máxima Center (NL)

3 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: NKUA (GR) to Hosting: Princess Máxima Center (NL)

6 months secondment, WP3 “Indentification and preclinical validation of new immune interventions”

Register to Apply
Sending: CUBA (SK) to Hosting: Region Hovedstaden-Rigs (DK)

6 months secondment, WP4 “Indentification and preclinical validation of new molecular interventions”

Register to Apply
Sending: CUBA (SK) to Hosting: Roche (CH)

6 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: CUBA (SK) to Hosting: Roche (CH)

6 months secondment,  WP5 “Repurposing of available therapeutic interventions”

Register to Apply
Sending: MSCCH (RO) to Hosting: Princess Máxima Center (NL)

6 months secondment,  WP6 “Clinical validation of high potential therapeutic interventions”

Register to Apply
Sending: MSCCH (RO) to Hosting: Institut Curie (FR)

5 months secondment,  WP6 “Clinical validation of high potential therapeutic interventions”

Register to Apply
Sending: MSCCH (RO) to Hosting: SJD (ES)

3 months secondment,  WP6 “Clinical validation of high potential therapeutic interventions”

Register to Apply
Sending: BKUS (LV) to Hosting: Open Position

6 months secondment,  WP6 “Clinical validation of high potential therapeutic interventions”

 

Register to Apply
Sending: KHCC (JO) to Hosting: Princess Máxima Center (NL)

6 months secondment,  WP6 “Clinical validation of high potential therapeutic interventions”

Register to Apply
Sending: KHCC (JO) to Hosting: SJD (ES)

6 months secondment,  WP6 “Clinical validation of high potential therapeutic interventions”

Register to Apply

We proudly partner with: